GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GB Sciences Inc (STU:18C) » Definitions » Total Liabilities

GB Sciences (STU:18C) Total Liabilities : €4.58 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is GB Sciences Total Liabilities?

GB Sciences's Total Liabilities for the quarter that ended in Dec. 2023 was €4.58 Mil.

GB Sciences's quarterly Total Liabilities increased from Jun. 2023 (€4.53 Mil) to Sep. 2023 (€4.62 Mil) but then declined from Sep. 2023 (€4.62 Mil) to Dec. 2023 (€4.58 Mil).

GB Sciences's annual Total Liabilities declined from Mar. 2021 (€10.32 Mil) to Mar. 2022 (€3.93 Mil) but then increased from Mar. 2022 (€3.93 Mil) to Mar. 2023 (€4.45 Mil).


GB Sciences Total Liabilities Historical Data

The historical data trend for GB Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GB Sciences Total Liabilities Chart

GB Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.39 13.07 10.32 3.93 4.45

GB Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.16 4.45 4.53 4.62 4.58

GB Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

GB Sciences's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.446+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=4.45

Total Liabilities=Total Assets (A: Mar. 2023 )-Total Equity (A: Mar. 2023 )
=0.329--4.116
=4.45

GB Sciences's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.511+(0.069+-0.0010000000000004
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=4.58

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=0.135--4.445
=4.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GB Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of GB Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


GB Sciences (STU:18C) Business Description

Traded in Other Exchanges
Address
9205 W. Russell Road, Suite 240, Las vegas, NV, USA, 89148
GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments.

GB Sciences (STU:18C) Headlines

No Headlines